RBC Capital Starts Infinity Pharmaceutical (INFI) at Outperform

November 21, 2012 6:42 AM EST Send to a Friend
Get Alerts INFI Hot Sheet
Price: $17.73 +3.14%

Rating Summary:
    11 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 28 | New: 51
Trade INFI Now!
Join SI Premium – FREE
RBC Capital initiates coverage on Infinity Pharmaceutical (NASDAQ: INFI) with a Outperform. PT $28.00.

For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.

Shares of Infinity Pharmaceutical closed at $23.45 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

RBC Capital

Add Your Comment